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Abstract 
Background: Medical doctors in Canada have a lack of education and understanding on how to 
safely prescribe opioids. Rural areas and Aboriginal populations have been identified as being at 
greater risk for opioid misuse. The purpose of this pilot project is to investigate barriers to rural 
physicians deprescribing opioids for noncancer pain in rural NL to better understand this under-
researched topic. Methods: Semi-structured interviews were conducted over the phone and audio 
recorded. The audio recordings were transcribed using Microsoft Word then thematically 
analysed. The themes were discussed with another team member to reach a consensus. Results: 
Three broad themes were identified including system related, provider related and patient related 
barriers with sub-themes under each. Interpretation: These preliminary results identified many 
barriers including lack of resources in rural areas, lack of provider education and lack of patient 
understanding of the mechanisms of opioid prescriptions that fit into three broad categories. 
Barriers not previously identified in the literature were acknowledged including lack of pain 
management resources in rural communities as well as patient misunderstanding opioid 
medication pharmacology. These results are preliminary and further research is required.  
Introduction 
Opioids are a class of drugs primarily prescribed as a pain reliever that can also cause an 
addictive and deleterious sense of well-being or euphoria (Canadian Center on Substance Abuse, 
2015).  With the second higher per capita rate of opioid prescription in the world (Gomes et al., 
2014), Canada’s situation ballooned into crisis in 2016 when British Columbia declared opioid 
misuse a public health emergency (BC Center for Disease Control, 2017) due to rising opioid-
related deaths in the province.  One approach to bring opioid use under control is deprescription, 
defined as an organized method of discontinuing a drug (Sivagnanam, 2016).  Indeed, 
deprescription has been endorsed by organizations like the National Advisory for Prescription 
Drug Misuse (Bhamb et al., 2006) to control misuse of opioids, yet very little is known about the 
barriers physicians face deprescribing, especially in rural areas.  Evidence suggests that areas 
with greater rural population have the largest amount of prescription opioid users (Keyes, Cerdà, 
Brady, Havens & Galea, 2014), a particularly important fact for the Canadian province of 
Newfoundland and Labrador (NL), where 41% of the population were living rurally (Statistics 
Canada, 2011) and there was an 84.7% increase in high dose opioid prescriptions from 2006 to 
2011, the largest increase in Canada (Dell et al., 2012). 
Research indicates that physicians lack comfort and training with respect to opioids (Jamison, 
Sheehan, Matthews, Scanlan & Ross, 2014; Turk, Brody, & Okifuji, 1994; Upshur, Luckmann & 
Savageau, 2006) and studies looking at methadone and benzodiazepines suggest physicians 
consider the length of time the patient had been on the therapy, return or symptoms and 
consequently, higher burden of care, as main barriers to deprescription (Bourgeios et al., 2014).  
Unfortunately, these studies do not offer much insight into the barriers to opioid deprescription 
and none with respect to rural settings, which come with unique contextual considerations, such 
as the stronger possibility of knowing patients within the community outside of the doctor patient 
relationship, as well as lack of access to other health services such as pain specialists and mental 
health services (Elliot & Westra, 2009). 
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The purpose of this project is to investigate barriers to rural physicians deprescribing opioids for 
noncancer pain in rural NL to better understand this under-researched topic.  However, for this 
pilot is to obtain two interviews to get preliminary feedback on feasibility to recruit participants, 
feasibility to conduct the interview including duration of the study, feasibility and relevance of 
the interview guide to explore the barriers to deprescribing opioids for noncancer and finally 
feasibility to conduct analysis.  
Research Question: What are the barriers to deprescribing opioids for noncancer pain in rural 
NL identified by rural physicians? 
Methodology 
Operational definitions of ‘rural’: areas with low population density, separated by a distance 
from areas of high density (Canadian Rural Revitalization Foundation, 2015). For this study 
defined by a rural postal code (Canada Post, 2015).  
Participants: Two primary care physicians with at least one year of active practice in rural NL 
who have experience working with patients that are on opioid medications.  
Study Setting: Goose Bay, a rural town in Labrador with a population of 8,109 (Statistics 
Canada, 2016). 
Recruitment: Emails were sent to potential participants after consulting with Dr. Everett 
Versteeg, the other primary investigator, on the project for recommendations for pilot interviews. 
Upon first contact, we forwarded the consent form disclosing all considerations of the project 
and their rights as a participant.  After receiving their signature, we contacted them to schedule 
an interview time.  
Methodological Approach: A medical student conducted semi-structured telephone interviews 
with the participants at a pre-arranged, mutually convenient time.  For sample interview 
questions and script see Appendix A.  The medical student was trained for semi-structured by the 
research team.  
Data Collection: Interviews were conducted by phone at the Health Science Center and audio 
recorded, with another member of the research team present to assist with any technical 
difficulties and probe for further information.  The medical student also took note of any issue 
during the interview, any comments arise by participants during the interview regarding the 
questions and recorded the duration of the interviews.  
Analysis: The audio recording was transcribed into Microsoft Word, then thematically analysed 
by highlighting key points in a printed copy of the transcript.  Key words and important themes 
were individually analysed from each interview and the highlighted sections were compared 
between the two transcripts for similarities.  Thematic analysis was chosen because the data is 
qualitative.  Time was given to reflect on the interview and the highlighted process was repeated 
to ensure no themes were missed.  Once the analysis was complete, the themes were discussed 
with a second team member who had also considered the interview data to reach a consensus on 
the themes.  
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Results 
After analyzing the data, a consensus was formed on three major broad themes and several sub-
themes under each broad theme.  The themes and subthemes of the barriers to opioid 
deprescription in Goose Bay along with participant quotes included:  
1. System-related Barriers 
a. Lack of formal resources such as suboxone or methadone or pain clinics 
“Having pain clinics for people with back pain, those are most prominent in my practice 
anyway, and having the pain clinic would be a real boom for those patients.  
That’s an impossible trip for most people who live here.  Despite there being 
some reimbursement that happens, the up-front cost is prohibitory.” 
 
b. Lack of specialty training in opioid deprescription 
“If there were some sort of interdisciplinary course or training program that 
pharmacists, pharmacy techs, nurses, mental health workers and everybody could 
take and engage in at the hospital, I think that would really improve education” 
 
c. Lack of interdisciplinary teams to support doctors guiding patient through 
deprescription 
“I think an interdisciplinary approach is necessary because it’s not a practical or 
realistic solution for physicians to be providing and doing direct observed 
therapy.” 
 
2. Provider-related Barriers 
a. Lack of formal training in pain management and opioid prescription 
“I don’t have that many patients on opioids, and I feel a bit like I don’t have a good 
toolbox for assessing patients as I am tapering them off.  I don’t have a 
standardized approach to it, I don’t really know what to expect and how to 
overcome these hurdles they are going to run into as they are weaning off their 
opioids.” 
 
3. Patient-related Barriers 
a. Fearing they cannot cope with their pain without opioids 
 
b. Patient misunderstanding of how opioids work and how discontinuing them will 
affect their pain 
“If they were to stop or discontinue their medicine over the course of a little while, their 
expectation is that they may go into fairly significant withdrawals and don’t have 
their safety blanket to temporize them.  There is a probably some truth to that but 
the reality of it is the pain, if they are taking the medicine for the pain, is likely 
worse in the long run from the secondary effects of opioid hyperalgesia than it 
would be if they weren’t taking it.” 
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In addition to the three major themes regarding barriers to opioid deprescription, participants 
were asked an extra question about how the interview guide and process could be improved.  
Both participants stated that the interview guide as well as the consent form were straightforward 
and easy to understand.  However, they stated that sending the interview questions to the 
interviewee prior to the interview would be beneficial to allow time for the participant to reflect 
on their thoughts as well as collect any relevant data from their patient base.  
Interpretation 
This pilot study showed the approach is feasible for participants recruitment and the interview 
guide is relevant to explore the barriers to deprescribing opioids for noncancer. The study 
suggests sending the interview guide to the participants before the interview would help form 
thoughtful points for discussion before the interview occurred.  
Several interesting themes that may be elucidated in future interviews, namely system, provider, 
and patient-related barriers. System related barriers are the lack of resources available in Goose 
Bay when compared to an urban center such as St. John’s. Specific resources include having a 
methadone or suboxone clinic as well as pain clinics which provide alternate therapies to control 
pain without opioids available in the community. The interviewees expressed fear of 
discontinuing opioids as a patient barrier. Having this resource available for patients, could help 
alleviate this fear knowing they will have a medication or alternate therapy to support them 
through the weaning process. This is in contradiction to the current literature on barriers to 
opioid prescription. Overarching issues present in the literature include a lack of formal training 
in opioid prescription as well as working with a patient population that includes older, male, low 
socioeconomic status and Aboriginal patients were identified as barriers (Holliday et al., 2015).  
However, working in a community lacking other pain management resources was not identified.   
Addressing this lack of resources could address the resource related barrier as well as a patient 
fear barrier.  
With respect to provider-related barriers, lack of formal education in pain management and 
opioid prescription was identified specifically during medical school training.  Not only is there a 
provider related barrier with regards to lack of education, but it is amplified by the lack of 
resources available to help support these gaps.  This is especially relevant for the rural physician 
who must see a wide variety of conditions, making it impossible to be an expert in everything 
they see. Prior research agrees that providing resources is helpful. For example, Srivastava et al. 
found that a pocket guide is beneficial to physicians as a reference in appointments, and 
similarly, participants in a study by Albert and colleagues (2011) noted that a prescriber toolkit 
was the most helpful tool available to them as part of their community based opioid prevention 
education. The use of telemonitoring in rural Ontario was used to allow pain specialists in bigger 
city centers to teach rural family doctors insights into pain management (Dubin et al., 2015).  
The doctors participating in this study reported feeling better equipped to deal with chronic pain 
patients and an increased sense of community with fellow doctors (Dubin et al., 2015). 
Patient-related barriers included the patient’s fear of discontinuing opioids and coping with their 
pain without them, as well as a misunderstanding of how deprescription of opioids will affect 
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their pain.  Patient demographics have been recognized as increasing the potential risk of opioid 
misuse in the literature as mentioned previously (Holliday et al., 2015).  However, patient fears 
and misunderstanding of opioid medications has not been quoted as a barrier thus far.  Although 
opioid hyperalgesia (a phenomenon occurring when chronic opioid use leads to increased 
sensitivity to noxious stimuli) is a well documented phenomenon, it has not been documented as 
a physician perceived barrier to prescribing or deprescribing opioids (Lee et al., 2011). Given the 
difficulty of explaining this concept to patient’s, having a health professional that was 
comparable to a diabetes educator but who had knowledge of opioid medications would help 
have these conversations with their patients was identified as being beneficial.  
Limitations of this study include a small sample size, and that both physicians interviewed 
practice in the same community.  Despite these limitations, the results of this pilot study 
demonstrate the feasibility of the recruitment, data collection and analyses. This pilot study also 
provided some early findings to be explored further in the qualitative study.  
Conclusion 
This pilot study suggests feasibility of the study.  It also suggests some modifications in the 
process of the interview including sending the questionnaire before the interview. The results 
presented here are preliminary and may evolve with further interviews; however, these results 
will form a useful basis as research continues.   
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Appendix A – Interview Questions and Script 
Hi, my name is Cassandra MacLean and I am a medical student conducting research on barriers 
to opioid deprescription in rural Newfoundland and Labrador.  I would like to ask you a few 
questions on this topic and the process should take about 30 minutes. 
1. How long have you been in rural practice? How long have you been prescribing opioids 
to patients? 
2. In your experience, what have been the biggest barriers when discontinuing opioid 
therapy with your patients?  Please explain. 
3. Are there any supports or resources available to you with respect to opioid 
deprescription? Please explain. 
4. Are there any barriers you see as specific to rural practice or Newfoundland/Labrador? 
Please explain. 
5. Do you have anything else to add or any questions for me? 
Thank you for your input and your time.  I will forward my results of this study when they are 
complete. 
 
 
 
 
 
